名稱 | PDL2/TCR Activator/CHO |
型號(hào) | CBP74065 |
報(bào)價(jià) | |
特點(diǎn) | PDL2/TCR Activator/CHO,凍存條件:90% FBS+10% DMSO; |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74065PDL2/TCR Activator/CHO
- 詳細(xì)內(nèi)容
PDL2/TCR Activator/CHO PDL2/TCR Activator/CHO PDL2/TCR Activator/CHO
I. Background | |
Programmed Cell Death Protein 1 (PD-1),一種在激活的 T 細(xì)胞上表達(dá)的受體,與其配 體 PD-L1 和 PD-L2 結(jié)合,負(fù)向調(diào)節(jié)免疫反應(yīng)。 PD-1 配體存在于大多數(shù)癌癥中,PD-1:PD- L1/2 相互作用會(huì)抑制 T 細(xì)胞活性,并使癌細(xì)胞逃避免疫監(jiān)視。 PD1/PDL1 信號(hào)轉(zhuǎn)導(dǎo)通路是 腫瘤免疫抑制的重要組成部分,可以抑制 T 淋巴細(xì)胞的興奮,增強(qiáng)腫瘤細(xì)胞的免疫耐受, 從而實(shí)現(xiàn)腫瘤免疫逃逸。PD1 與 PDL1 結(jié)合可以減弱 T 細(xì)胞介導(dǎo)的免疫監(jiān)視,導(dǎo)致免疫反 應(yīng)缺失,甚至導(dǎo)致 T 細(xì)胞凋亡。PD1/PDL1 抑制劑可解除抗腫瘤 T 細(xì)胞的免疫抑制,從而 導(dǎo)致 T 細(xì)胞增殖并滲透到腫瘤微環(huán)境中并誘導(dǎo)抗腫瘤反應(yīng)。PD-1:PD-L1/2 通路還參與調(diào)節(jié) 自身免疫反應(yīng),使這些蛋白質(zhì)成為多種癌癥以及多發(fā)性硬化癥、關(guān)節(jié)炎、狼瘡和 I 型糖尿 病的有希望的治療靶點(diǎn)。磷酸酶 SHP2 是 T 細(xì)胞功能的關(guān)鍵調(diào)節(jié)因子,它介導(dǎo) TCR 下游的激活信號(hào)以及 PD-1 下游的抑制信號(hào)。 | |
II. Description | |
PDL2 TCR Activator CHO 細(xì)胞作為 PD1 NFAT-Luc Jurkat 細(xì)胞的靶細(xì)胞,很好的模擬了 體內(nèi) PD1&PDL2 的信號(hào)轉(zhuǎn)導(dǎo)過程,原理見下圖所示。 Figure 1. PDL2 TCR Activator CHO 細(xì)胞模型原理圖 | |
III. Introduction | |
Host Cell: | CHO-K1 |
Expressed gene: | PDL2 |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Synonym(s): | Programmed Cell Death 2 Ligand 2, PDL2, PD-L2, CD273, PDCDL1G2, B7-DC |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12K+10%FBS+2ug/ml puromycin+500ug/ml hygromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
Application(s): | Functional(Report Gene) Assay |
IV. Description of Host Cell Line | |
Organism: | Cricetulus griseus, hamster, Chinese |
Tissue: | Ovary |
Disease: | Hamster Chinese ovary |
Morphology: | Epitheloid cell |
Growth Properties: | Adherent |
Ⅴ. Representative Data |
Figure 2.Recombinant PDL2/TCR Activator/CHO constitutively expressing PDL2.
Figure 3. Dose Responese of anti-PD-1 neutralizing antibody in PD1 NFAT-Luc Jurkat (C16) with PDL2 TCR Activator CHO.